Rey F, Abadie V, Plainguet F, Rey J
Hôpital des Enfants Malades, Paris, France.
Eur J Pediatr. 1996 Jul;155 Suppl 1:S39-44. doi: 10.1007/pl00014246.
The age for discontinuing dietary treatment of phenylketonuria (PKU) has been a worldwide source of controversy for many years. It is the reason we report here the results of a prospective, controlled study in which the diet was relaxed at 5 years of age in 31 so far well-treated children with classical PKU. The increase of phenylalanine (Phe) plasma levels to about 1500 mumol/l (25 mg/dl) after relaxing the diet was not associated with any significant decline of intellectual performance as measured by the Wechsler scores. Paired comparisons at 7-8 years and 11-13 years of age (n = 12) have shown WISC scores of 102.6 +/- 16.2 and 104.8 +/- 16, respectively, which were not significantly different. Similarly, paired comparisons at 9-10 years and 14-16 years (n = 6) did not demonstrate a significant loss of IQ points (107.7 +/- 13 vs 104.8 +/- 18). Of course, it is possible to argue that we should have observed an increase in IQ with increasing age in our patients and that the absence of deterioration cannot be considered by itself as a good result. Nevertheless, it cannot be excluded that the subtle but global intellectual impairments that have been documented in early-treated subjects are, to a very substantial degree, determined in the pre-school years, long before there is any question of stopping or relaxing the diet.
多年来,苯丙酮尿症(PKU)饮食治疗的终止年龄一直是一个全球性的争议焦点。这就是我们在此报告一项前瞻性对照研究结果的原因,该研究中,对31名迄今治疗良好的典型PKU患儿在5岁时放宽了饮食限制。放宽饮食后,血浆苯丙氨酸(Phe)水平升高至约1500 μmol/l(25 mg/dl),但根据韦氏评分衡量,智力表现并未出现任何显著下降。在7 - 8岁和11 - 13岁(n = 12)进行的配对比较显示,韦氏儿童智力量表(WISC)评分分别为102.6 ± 16.2和104.8 ± 16,无显著差异。同样,在9 - 10岁和14 - 16岁(n = 6)进行的配对比较也未显示智商分数有显著下降(107.7 ± 13对104.8 ± 18)。当然,可以认为我们本应观察到患者的智商随年龄增长而提高,而且没有恶化本身不能被视为一个好结果。然而,不能排除的是,在早期接受治疗的患者中记录到的细微但全面的智力损害,在很大程度上是在学龄前就已确定,远在考虑停止或放宽饮食之前。